RIVASTIGMINE VIATRIS 4,6 mg/24 heures, dispositif transdermique

Products recorded under this name, by market (identity only).

Also written as: RIVASTIGMINE VIATRIS 9,5 mg/24 heures, dispositif transdermique · Found in: FR

Same name does not mean interchangeable — identity is matched field by field, as recorded.